Search PubMedSearch

PubMed · 1272595

On the phosphate problem.

Abstract

Acceptable Daily Intakes (ADI) of phosphorus set by the FAO/WHO Committee are fixed at 70 and 30 mg P/kg body weight, for conditional (C) (where Ca intake is high) and unconditional (UC) intake, respectively. In light of the increasing application of phosphates in food industries, the question arises whether these permissible limits are not exceeded by certain population group (s). The groups studied in this paper included: children, nursing mothers, farmers and town's men, and students. Average per capita and excessive consumptions were also estimated. Spectrometric techniques were used for analysis of both phosphorus and calcium. Unless for few items, Dutch Food Composition Tables were found accurate enough to use for calculations. Intake of P was found to exceed the UC ADI in most groups, and even the C ADI in infants (1 year). Food intakes of all groups resulted in P/Ca ratios higher than the recommended dietary allowances of U.S.A. Milk and dairy products proved important items for lowering this ratio in the Dutch diet. It is concluded that more investigation for the toxicological evaluation of phosphates is required, and a more clear ADI need be set. Food laws must take into account addition of phosphates during food processing. Estimation of P intake should be carried out particularly in countries of low calcium intake or high consumption of phosphate-treated or phosphate-rich foods (e.g. wholemeal bread and nut consumption in Iran).

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

M I El-Shaarawy, J F Reith. 1976. On the phosphate problem.. https://pubmed.ncbi.nlm.nih.gov/1272595/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

The structural features of concanavalin A governing non-proline peptide isomerization.

The reversible binding of manganese and calcium to concanavalin A determines the carbohydrate binding of the lectin by inducing large conformational changes. These changes are governed by the isomerization of a non-proline peptide bond, Ala-207-Asp-208, positioned in a beta-strand in between the calcium binding site S2 and the carbohydrate specificity-determining loop. The replacement of calcium by manganese allowed us to investigate the structures of the carbohydrate binding, locked state and the inactive, unlocked state of concanavalin A, both with and without metal ions bound. Crystals of unlocked metal-free concanavalin A convert to the locked form with the binding of two Mn(2+) ions. Removal of these ions from the crystals traps metal-free concanavalin A in its locked state, a minority species in solution. The ligation of a metal ion in S2 to unlocked concanavalin A causes bending of the beta-strand foregoing the S2 ligand residues Asp-10 and Tyr-12. This bending disrupts conventional beta-sheet hydrogen bonding and forces the Thr-11 side chain against the Ala-207-Asp-208 peptide bond. The steric strain exerted by Thr-11 is presumed to drive the trans-to-cis isomerization. Upon isomerization, Asp-208 flips into its carbohydrate binding position, and the conformation of the carbohydrate specificity determining loop changes dramatically.

Calcium

Phosphorylation of myosin light chain kinase by p21-activated kinase PAK2.

Phosphorylation of myosin II regulatory light chains (RLC) by Ca(2+)/calmodulin-dependent myosin light chain kinase (MLCK) is a critical step in the initiation of smooth muscle and non-muscle cell contraction. Post-translational modifications to MLCK down-regulate enzyme activity, suppressing RLC phosphorylation, myosin II activation, and tension development. Here we report that PAK2, a member of the Rho family of GTPase-dependent kinases, regulates isometric tension development and myosin II RLC phosphorylation in saponin permeabilized endothelial monolayers. PAK2 blunts tension development by 75% while inhibiting diphosphorylation of myosin II RLC. Cdc42-activated placenta and recombinant, constitutively active PAK2 phosphorylate MLCK in vitro with a stoichiometry of 1.71 +/- 0. 21 mol of PO(4)/mol of MLCK. This phosphorylation inhibits MLCK phosphorylation of myosin II RLC. PAK2 catalyzes MLCK phosphorylation on serine residues 439 and 991. Binding calmodulin to MLCK blocks phosphorylation of Ser-991 by PAK2. These results demonstrate that PAK2 can directly phosphorylate MLCK, inhibiting its activity and limiting the development of isometric tension.

Calcium

Recombinant fibrinogen Vlissingen/Frankfurt IV. The deletion of residues 319 and 320 from the gamma chain of firbinogen alters calcium binding, fibrin polymerization, cross-linking, and platelet aggregation.

We synthesized a variant, recombinant fibrinogen modeled after the heterozygous dysfibrinogen Vlissingen/Frankfurt IV, a deletion of two residues, gammaAsn-319 and gammaAsp-320, located within the high affinity calcium-binding pocket. Turbidity studies showed no evidence of fibrin polymerization, although size exclusion chromatography, transmission electron microscopy, and dynamic light scattering studies showed small aggregates. These aggregates did not resemble normal protofibrils nor did they clot. Fibrinopeptide A release was normal, whereas fibrinopeptide B release was delayed approximately 3-fold. Plasmin cleavage of this fibrinogen was not changed by the presence of calcium or Gly-Pro-Arg-Pro, indicating that both the calcium-binding site and the "a" polymerization site were non-functional. We conclude that the loss of normal polymerization was due to the lack of "A-a" interactions. Moreover, functions associated with the C-terminal end of the gamma chain, such as platelet aggregation and factor XIII cross-linking, were also disrupted, suggesting that this deletion of two residues affected the overall structure of the C-terminal domain of the gamma chain.

Calcium